Breaking News on Contract Research, Manufacturing & Clinical Trials

Headlines > Preclinical Research

AMRI: discovery services demand still strong despite closing NY plant

17-Apr-2014 - AMRI says its long-term outlook remains positive with continued demand for its contract research services despite plans to shutter a Discovery and Development Services facility.

Debiopharm selects CRO Evotec for early cancer drug discovery deal

08-Apr-2014 - CRO Evotec AG will help Debiopharm identify and develop novel compounds with the potential to treat multiple forms of solid tumours and leukaemias with defined genetic alterations under a collabortation announced...

Completed Galapagos deal to boost 2014 sales by $70m for Charles River

02-Apr-2014 - Argenta and BioFocus will add approximately $70m (€51m) to Charles River Laboratories’ 2014 revenues, the firm and an analyst say.

Convergence selects Evotec to help develop pain treatment

01-Apr-2014 - Convergence Pharmaceuticals has entered into a research alliance with CRO Evotec to discover and develop compounds against a novel GPCR pain target.

Biotech and pipeline refills add to preclinical turnaround, say analysts

27-Mar-2014 - Demand from biotech firms and Big Pharma’s need to refill its pipeline is driving the preclinical services industry, say analysts at this year’s Society of Toxicology (SOT) meeting.

Hey rat fans, BioReliance has a Big Blue genotoxicity assay for you

26-Mar-2014 - BioReliance has updated its big blue assay for the second time in six months by creating a version of the drug genotoxicity test that can be used in rats.

Drugmakers start your engines: GSK's Formula One discovery formula

26-Mar-2014 - GSK has asked Formula One team Mclaren to help it discover drugs, arguing that Big Data expertise from outside the contract research sector can accelerate its efforts to develop new...

Covance to bring more biologics bioanalysis capacity online in 2014

25-Mar-2014 - Covance has announced that its recently expanded large molecule bioanalytical space at its laboratory facility in Indianapolis will come online in late 2014.

Evotec buys academic asset management specialist

24-Mar-2014 - Evotec AG has bought an asset management company that specialises in bringing academic discovery and development innovations to the attention of pharma and biopharma sponsors.

Exclusive interview

‘Arrogance’ and animal testing: the hurdles to outsourcing

17-Mar-2014 - Pharmaceutical companies need to change their attitudes to contractors, says the former director of Shire’s relationships with its 100 outsourcing partners.

breaking news - update 2

CRL to buy Argenta and Biofocus from Galapagos for €134m

13-Mar-2014 - Preclinical CRO Charles River Labs has announced plans to buy discovery services firms Argenta and BioFocus from Galapagos NV.

Harlan and Bertin team to target discovery and translational meds market

05-Mar-2014 - Harlan is looking to take advantage of a dearth of new products in pharma clients’ pipelines with an early drug development partnership with France’s Bertin Pharma.

Venn buys human skin substitute

04-Mar-2014 - Clinical research group Venn Life Sciences has acquired the rights to LabSkin (pictured), a human skin substitute that behaves like the real thing, from dermatology CRO Evocutis.

Novartis closing UK site, but will $1m per week R&D spend benefit CROs?

27-Feb-2014 - Novartis says it will continue to spend around $1m a week on clinical trials in the UK after its R&D site closes in June.

Horizon IPO to raise $42m for R&D personalised medicine services

27-Feb-2014 - With a drive towards personalised medicine, Big Pharma is acting like mini-biotech firms in its approach to R&D, says Horizon Discovery who is launching a £25m ($42m) IPO.

Charles River launches new quality control service for biotech and pharma industry

20-Feb-2014 - CRO Charles River Laboratories launched today a new insourcing/outsourcing option for its clients to improve their quality control.

Canadian CRO partners with Italian CRO for imaging services

18-Feb-2014 - Canadian CRO ADA Medical will collaborate with Italy’s Ephoran Multi-Imaging Solutions to expand into the pre-clinical research space. 

MPI Research, 3D Imaging and inviCRO team up for imaging centre

12-Feb-2014 - MPI Research, inviCRO and 3D Imaging have partnered to build a Translational Imaging Center, providing molecular imaging, autoradiography, and animal modelling for pharmaceutical clients to investigate drug candidates.

CRL to close MI research model unit, as preclinical biz blossoms

12-Feb-2014 - Charles River Laboratories says it will shutter a Research Models and Services (RMS) facility in Michigan as softened demand for the sector offset a strong year for its preclinical service...

NIH partners with 10 pharma companies to tackle major disease targets

11-Feb-2014 - The National Institutes of Health and 10 pharmaceutical companies have launched a partnership to transform the current model for identifying and validating promising biological targets for Type 2 diabetes, Alzheimer’s...

Covance sells 'underperforming' site to LabCorp; Reports strong Q4

05-Feb-2014 - Covance has sold its high-complexity genomics laboratory to LabCorp as part of what an analyst says is decisive action to shed underperforming assets in its Early Development business.

Harlan sets up first animal breeding facility in India

21-Jan-2014 - CRO Harlan Laboratories announced that it will open its first oncology research model breeding facility in India, which has already sparked anger in the animal rights community. 

Sigma-Aldrich launches 'knock-out' way to create liver toxicity assays

21-Jan-2014 - Sigma-Aldrich has teamed with Biopredic to produce genetically-modified human liver cell lines and assays it says can cut costs by reducing animal toxicology studies in drug discovery.

CRL looks to strategic alliances to drive growth across changing clientbase

20-Jan-2014 - Strategic relationships with both big pharma and mid-tier firms will drive future growth, says Charles River laboratories (CRL).

Covance demolishes unfinished $175m lab in Virginia

16-Jan-2014 - As part of its shift to cut costs, Covance has demolished an unfinished $175m (€128m) toxicology laboratory it was building in Manassas, Virginia.

Key Industry Events

Interphex 2014

New York, NY 10001 / Conference and exhibition

Read more

Access all events listing